Wouter E.M. Kok
- Cardiology and Cardiovascular Medicine top 1%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 2%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Yigal M. PintoLeontien C.M. KremerAllard C. van der WalElvira C van DalenHelena J. H. van der PalHuib N. CaronFlora E. van LeeuwenAnke J. Tijsen
- Topics
- Heart Failure Treatment and Management (23 papers)Chemotherapy-induced cardiotoxicity and mitigation (17 papers)Childhood Cancer Survivors' Quality of Life (15 papers)
- Cited by
- Cardiology and Cardiovascular MedicineCancer ResearchPediatrics, Perinatology and Child Health
- Partner nations
- NetherlandsItalySpain
In The Last Decade
Wouter E.M. Kok
64 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cardiology and Cardiovascular Medicine 1.8k
- Molecular Biology 569
- Pediatrics, Perinatology and Child Health 510
- Pulmonary and Respiratory Medicine 491
- Cancer Research 452
Countries citing papers authored by Wouter E.M. Kok
This map shows the geographic impact of Wouter E.M. Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter E.M. Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter E.M. Kok more than expected).
Fields of papers citing papers by Wouter E.M. Kok
This network shows the impact of papers produced by Wouter E.M. Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter E.M. Kok. The network helps show where Wouter E.M. Kok may publish in the future.
Co-authorship network of co-authors of Wouter E.M. Kok
This figure shows the co-authorship network connecting the top 25 collaborators of Wouter E.M. Kok. A scholar is included among the top collaborators of Wouter E.M. Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter E.M. Kok. Wouter E.M. Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 6 | |
| 5 | 12 | |
| 6 | 11 | |
| 7 | 1 | |
| 8 | 101 | |
| 9 | 10 | |
| 10 | 26 | |
| 11 | 13 | |
| 12 | 95 | |
| 13 | 140 | |
| 14 | 1 | |
| 15 | 205 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 26 | |
| 20 | 16 |
About Wouter E.M. Kok
Wouter E.M. Kok is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Pediatrics, Perinatology and Child Health, having authored 69 papers that have together received 2.9k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (23 papers), Chemotherapy-induced cardiotoxicity and mitigation (17 papers) and Childhood Cancer Survivors' Quality of Life (15 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.8k citations), Cancer Research (452 citations) and Pediatrics, Perinatology and Child Health (510 citations). Wouter E.M. Kok has collaborated with scholars based in Netherlands, Italy and Spain. Frequent co-authors include Yigal M. Pinto, Leontien C.M. Kremer, Allard C. van der Wal, Elvira C van Dalen, Helena J. H. van der Pal, Huib N. Caron, Flora E. van Leeuwen, Anke J. Tijsen, Perry D. Moerland and Esther E. Creemers. Their work appears in journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.